ATE304370T1 - Verwendung von efrapeptin oligopeptiden zur hemmung der angiogenese - Google Patents

Verwendung von efrapeptin oligopeptiden zur hemmung der angiogenese

Info

Publication number
ATE304370T1
ATE304370T1 AT02016402T AT02016402T ATE304370T1 AT E304370 T1 ATE304370 T1 AT E304370T1 AT 02016402 T AT02016402 T AT 02016402T AT 02016402 T AT02016402 T AT 02016402T AT E304370 T1 ATE304370 T1 AT E304370T1
Authority
AT
Austria
Prior art keywords
angiogenesis
inhibit angiogenesis
efrapeptin
oligopeptides
efrapeptin oligopeptides
Prior art date
Application number
AT02016402T
Other languages
English (en)
Inventor
Antonia Papathanasiou
Original Assignee
Antonia Papathanasiou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antonia Papathanasiou filed Critical Antonia Papathanasiou
Application granted granted Critical
Publication of ATE304370T1 publication Critical patent/ATE304370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AT02016402T 2002-07-22 2002-07-22 Verwendung von efrapeptin oligopeptiden zur hemmung der angiogenese ATE304370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02016402A EP1384484B1 (de) 2002-07-22 2002-07-22 Verwendung von Efrapeptin Oligopeptiden zur Hemmung der Angiogenese

Publications (1)

Publication Number Publication Date
ATE304370T1 true ATE304370T1 (de) 2005-09-15

Family

ID=29797159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02016402T ATE304370T1 (de) 2002-07-22 2002-07-22 Verwendung von efrapeptin oligopeptiden zur hemmung der angiogenese

Country Status (3)

Country Link
EP (1) EP1384484B1 (de)
AT (1) ATE304370T1 (de)
DE (1) DE60206153T2 (de)

Also Published As

Publication number Publication date
DE60206153T2 (de) 2006-07-27
EP1384484A1 (de) 2004-01-28
DE60206153D1 (de) 2005-10-20
EP1384484B1 (de) 2005-09-14

Similar Documents

Publication Publication Date Title
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
ATE406170T1 (de) Kontrolle des proteinspiegels in eukaryotischen organismen
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE499934T1 (de) Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
DE50310516D1 (de) Fredericamycin-derivate
ATE556713T1 (de) Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
ATE520691T1 (de) Shp-2-hemmer, pharmazeutische zusammensetzung damit und ihre verwendung zur behandlung phosphatase-vermittelter erkrankungen
DE60233261D1 (de) Inhibitoren von humanem adam-10
DE60140871D1 (de) Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase
ATE448785T1 (de) Behandlung von entzündlicher darmerkrankung
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
ATE338036T1 (de) Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate
SE0302312D0 (sv) Peptide-based passive immunization therapy for treatment of atherosclerosis
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE60206153D1 (de) Verwendung von Efrapeptin Oligopeptiden zur Hemmung der Angiogenese
BRPI0415355A (pt) triarilimidazóis
DE60311822D1 (de) Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties